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In the presence of certain metals, regions of the hormone binding domain of the glucocorticoid receptor (GR) are capable of binding the 90 kDa 
heat shock protein (hsp90). Using secondary structure prediction methods m correlation with the experimental data, we propose a model which 
predicts the presence of two widely spaced leucine zipper-like heptads on either side of a central subdomain. The heptads could interact 
hydrophobically with similar regions on the hsp90 homodimer, bringing putative metal binding residues on each protein close enough to establish 
a shared metal bridge. The central subdomain between heptads is suggested to contain regions mvolved in metal binding, steroid binding, and 
conformational mobility. The hypothetical model that we are proposing therefore addresses the nature of the structural link between hsp90 binding, 
hormone binding, and conformational changes in the receptor. 
Glucocorticoid receptor: 90 kDa heat shock protein; Leucine zipper 
1. INTRODUCTION 
Binding of glucocorticoids to their cognate receptor 
in the cell initiates a chain of events which ultimately 
leads to changes in gene expression. As part of this 
process, the receptor binds to hsp90 at or near the end 
of translation to form the 8s complex [1,2]. It has been 
suggested that the interaction with hsp90 assists in the 
correct folding of the receptor [3,4]. The formation of 
the 8s complex promotes the high affinity ligand bind- 
ing conformation of the glucocorticoid receptor [5-71. 
Conformational changes induced by hormone binding 
have been linked to dissociation of hsp90 from the com- 
plex [7]. The receptor is then capable of DNA binding, 
homodimerization, and altering gene expression [8,9]. 
Evidence indicates that neither the amino terminal 
nor the DNA binding domains of the glucocorticoid 
receptor are primarily responsible for binding hsp90, 
but rather several different sites within the hormone 
binding domain are involved in the formation of a sta- 
ble complex [lo]. These and other results further indi- 
cate that the hormone-binding domain is a complex 
structure containing several overlapping, multifunc- 
tional regions for ligand binding, dimerization, tran- 
scription activation and hsp90 binding [4-7,9-181. 
However, little is known about either the secondary 
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structure of the receptor or the conformational changes 
related .to hormone binding and the dissociation of 
hsp90. By correlating the experimental data on receptor 
function with secondary structure predictions [ 19,201, 
we describe a model for the hsp9&GR interaction 
which links the structure and the functions of the gluco- 
corticoid receptor. 
2. HYPOTHESIS 
We propose that two separate regions within the 
hormone binding domain of the monomeric glucocorti- 
coid receptor form weak leucine-zippers with the hsp90 
homodimer. A hypothetical central subdomain between 
helices contains regions which contribute to steroid 
binding, conformational mobility, and metal binding. 
The partial overlap of these regions in the primary 
structure of the protein (Fig. 1) would produce a ligand- 
sensitive, conformationally controlled, regulatory site 
within the receptor. Steroid binding is predicted to in- 
duce a transition in the conformationally mobile region 
from a random to a helical state. This could, in turn, 
disrupt the metal link and promote hsp90 release. Fur- 
ther conformational changes could then take place in 
the receptor which block hsp90 reassociation and favor 
homodimerization. 
2.1. Weak leucine zipper interactions 
Weak leucine zippers are suggested to form between 
Region C on hsp90 [21] and LZ-1 and LZ-2 on the 
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Fig. 1. Predicted subdomain structure for the hGR hormone binding 
domain. Two separate leucine zipper-like regions (LZ-1 and LZ-2) 
flank the central subdomain. The central subdomain consists of three 
partially overlapping regions which function in ligand binding (verti- 
cal stripes), conformational mobility (horizontal stripes), and metal 
binding. The metal binding region may extend into the flanking leuc- 
ine zippers, as discussed in the text. Residues which can be labelled 
with ligand [33-351, including cysteines with potential for metal bind- 
mg, are circled. Shown above are the 16 kDa core hormone binding 
fragment [40], solid box, and delimited segments required for tight 
hormone binding [33,38840], shaded boxes. The numbers shown cor- 
respond to amino acid positions in the human glucocorticoid receptor. 
glucocorticoid receptor (Fig. 2). Region C was chosen 
because it contains a leucine zipper-like M-L-L-L se- 
quence, 1 cysteine, is devoid of proline, and is predicted 
to have high a-helical content. Furthermore, this region 
is located within a larger segment which is crucial to the 
steroid receptor-hsp90 interaction [22]. There are no 
perfect leucine zippers within the hormone-binding do- 
main of the glucocorticoid receptor. Two helices, how- 
ever, were selected from several other, conformationally 
discrete, helical heptad repeats because their involve- 
ment in hsp90 binding is consistent with the experimen- 
tal data, their surfaces show high compatibility for 
hsp90 binding, and they border the central subdomain 
and thereby fit a similar model proposed for the estro- 
gen receptor [21]. 
The model predicts that the association between pro- 
teins is relatively weak. First, there are few salt bridges 
to stabilize the hydrophobic interaction (Figs. 3 and 4). 
Second, the glucocorticoid receptor heptads are pre- 
dicted to be short and kinked or broken (Fig. 2). Third, 
A. 
the presence of like charges close to each other would 
destabilize the interaction between helices (Figs. 3 and 
4). These characteristics correlate well with observa- 
tions that the SS complex is readily dissociated by in- 
creased temperature, dilution, changes in pH, chelation 
of metal ions, and hormone binding. 
2.2. Metal binding 
The first functionally distinct region in the central 
subdomain is the hypothetical metal binding region. This 
region contains amino acid residues such as cysteine 
which are capable of binding metals. Also, this region 
is predicted to become buried in a hydrophobic inter- 
face between the glucocorticoid receptor and a similar 
potential metal binding region on the hsp90 homo- 
dimer. The leucine zippers formed between the glucocor- 
ticoid receptor and the hsp90 homodimer are predicted 
to bring the metal binding residues on each protein close 
enough to form a shared metal binding site (Fig. 2). A 
shared metal binding site [23] has also been shown to 
be involved in dimerization of the MerR metalloregula- 
tory protein [24] and in the binding of growth hormone 
to the prolactin receptor [25]. Two other proteins the 
binding of which to hsp90 is stabilized by molybdate 
[26.27], v-erb A and pp60”~““. have sequences which are 
similar to the putative metal-binding region of this 
model. 
Divalent zinc was previously suggested to bridge 
hsp90 and the androgen receptor in the 8s complex [28]. 
Exogenous transition metal oxyanions, such as mo- 
lybdate. stabilize the hsp90-bound form of the steroid 
receptors. Other experiments using glucocorticoid re- 
ceptor-containing cytosols have demonstrated that an 
endogenous heat stable, chelatable, anionic, molybdate- 
like factor stabilizes the hsp90-glucocorticoid receptor 
complex [29]. A direct physical interaction between 
hormone-binding domain cysteine sulthydryl groups on 
the glucocorticoid receptor and molybdate has been 
shown [32]. In the present model, two alternative metal 
binding centers between the glucocorticoid receptor and 
Region C on the hsp90 dimer have been constructed: ( 1) 
0. 
hGF! U-1 
Fig. 2. Schematic representation of the gapped ztpper arrangement between LZ-1 and LZ-2 on the hGR monomer and Region C on the hsp90 
dimer. The central subdomam, or gap between helices. on the hGR, encompasses regions which contribute to sterord binding, N-terminal to the 
boxed cysteine; conformational mobility, C-terminal to the boxed cysteine; and metal binding,. The metal binding region is depicted as a single 
(A) or double (B) metal ion coordinatton site. 
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Fig. 3. Hydrophobic interactions between weak leucme zippers. Helical wheel (top) and hehcal net (bottom) diagrams how the proposed interactive 
surfaces between hsp90 Region C and one of two possible arrangements for LZ-1, denoted as a or b. Predicted hydrophobic pockets and favorable 
electrostatic interactions are shaded. Parentheses indicate potential breaks in the helical structure. 
where cysteine ligands within the steroid binding and 
conformationally mobile regions coordinate a single 
metal ion (Fig. 2A) or, (2) where additional cysteines in 
LZ-1 and LZ-2 allow two metal ions to be bound (Fig. 
2B). Cysteine ligands were used for modeling because 
(1) molybdate is known to bind sulfhydryl groups [30]; 
(2) cysteine binds metals in other proteins [31], and (3) 
molybdate interacts directly with hormone binding do- 
main cysteines (321. However, additional experiments 
are required to identify the actual metal-binding resi- 
dues. 
Interestingly, the secondary structure modeling ex- 
periments (Figs. 3 and 4) place a cysteine near to a lysine 
in both LZlb and LZ2. The positively charged lysines 
could therefore lower the pK and stabilize the thiolate 
anion form of the nearby cysteine residues; this would 
favor metal binding. 
Two studies using deletion mutants [ 13,181 and syn- 
thetic peptides [18] support the proposed model. These 
experiments identified two critical contact sites for 
hsp90 binding. One site, corresponding on the human 
GR (hGR) to residues 626653. was suggested to con- 
tain the metal anion binding site [13]; the other, corre- 
sponding on the hGR to residues 568-653, was pro- 
posed to provide additional contacts for the hsp9O-CR 
interaction 1181. These segments coincide with the core 
metal binding region and LZl of the model described 
here (Fig. 2A). 
2.3. Hormone binding 
The hypothetical hormone binding segment is the sec- 
ond functionally distinct region in the central subdo- 
main (Fig. 1). This region contains residues that have 
been implicated in binding hormone, such as methion- 
ine-604 and hormone binding domain thiol groups [33- 
35] (Fig. 1). Most insertions, deletions and point muta- 
tions within the hormone binding domain cause a re- 
duction in steroid binding activity [36,37]. However, 
several delimited segments have also been implicated in 
tight hormone binding [33,34,38840] (Fig. 1). Among 
these is the trypsin-generated, 16 kDa core fragment 
which binds hsp 90 and hormone but with a 23-fold 
reduction in affinity for the latter [40]. These data indi- 
cate that nearly all portions of the glucocorticoid recep- 
tor hormone binding domain are either directly or indi- 
rectly involved in the formation of the high affinity 
steroid binding site. The proposed model, by describing 
the hormone binding domain as having overlapping 
segments with specialized, yet interde~ndent functions, 
accounts for these observations. Furthermore, the 16 
kDa core hormone binding fragment spans LZl, the 
ligand binding subdomain, and much of the metal bind- 
ing region proposed here; most of the other segments 
required for tight hormone binding [33,34,38,39] coin- 
cide with the confo~ationally mobile or LZ2 regions 
(Fig. 1). Finally, low levels of arsenite, which may bind 
vicinal dithiols, were shown to block steroid binding 
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activity and affinity fabeling [41.42]. The blockage of 
affinity labeling was reversible by DTT [43]. These vici- 
nai dithiols are present in the ligand and metal binding 
regions proposed here (Fig. 1). 
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Fig. 4. hydrophobic interactions between weak leucine zippers. Heli- 
cal wheel (top) and helical net (bottom} diagrams showing the pro- 
posed interactive surfaces between hsp90 Region C and LZ-2. Pre- 
dicted hydrophobtc pockets and favorable electrostatic interactions 
are shaded. 
Fig. 5. Potential homodimerization site. Helical wheel (top) and helical 
net (bottom) representation between conformationally mobile regions 
when drawn as an a-helix. Potentially reactive residues are shaded. 
Note the preponderance of hydrophobrc residues at predicted interac- 
tive surfaces as shown in the helical net diagram. 
2.4. Conformational mobility 
The third functionally distinct site in the central sub- 
domain is the hypothetical conformationally mobile re- 
gion, which has equal Chou-Fasman [19] helix- and 
sheet-forming predictions. For example, ambiguous 
predictions for the peptide hormone glucagon corre- 
lated with structural changes from CIV 01 helix to a 
/3 sheet upon binding to the receptor [44]. Similarly, a 
segment of preproparathyroid hormone which has am- 
biguous predictions undergoes conformational change 
in response to changes in solvent hydrophobicity [44]. 
We propose that steroid binding to the hormone-bind- 
ing segment of the receptor shifts the conformation of 
the neighboring mobile region from that of a coil to that 
of a helix. One possible mechanism is through an in- 
crease in the local hydrophobicity brought about by 
steroid binding. Furthermore, the conformationally 
mobile region, when modeled as an a helix, forms a 
potential homodime~ation site (Fig. 5). A change in 
the secondary structure, as suggested here, could there- 
fore favor homodimerization as well as impair hsp90 
reassociation. 
Because the conformationally mobile region is pre- 
dicted to contain at least one of the amino acids in- 
volved in metal binding, the changes induced by steroid 
binding are predicted to weaken the metal link between 
the receptor and hsp90. Once this occurs, the weak leuc- 
ine zipper would be insufficient to maintain the hsp90- 
GR interaction and the proteins would dissociate. Addi- 
tional conformational changes could then take place in 
the receptor making hsp90 binding sites inaccessible, 
reassociation difficuit, and favoring homodimerization. 
This reasoning agrees with studies which show that 
reassociation of hsp90 with the transformed GR has 
only been achieved in the presence of rabbit reticulocyte 
lysate [45]. 
The proposed model is consistent with the available 
experimental evidence that multiple regions of the GR 
hormone binding domain are involved in hsp90 bind- 
ing. and suggests a potential mechanism which links 
hormone binding with conformational changes in the 
receptor. We hope that it will assist in the interpretation 
of current results and serve as a guide for future exper- 
iments. 
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